Suarez et al. employed CAR T-cells targeting carbonic anhydrase IX (CAIX) expressed on metastatic clear cell renal cell carcinoma (ccRCC) in combination with programmed death ligand-1 (PD-L1) antibodies (63). This evidence concerns the gene CA9 and nonpapillary renal cell carcinoma.